Recombinant MLANA 抗体 (full length)
Quick Overview for Recombinant MLANA 抗体 (full length) (ABIN7477517)
抗原
See all MLANA 抗体抗体类型
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- full length
-
原理
- Melan A CR (Cross Reactive) antibody (901M+)
-
免疫原
- Recombinant full-length hMART-1 protein
-
亚型
- IgG1, kappa
-
-
-
-
应用备注
- IHC 1:50-1:100
-
说明
-
Positive Control: Skin: Virtually all melanocytes should show a strong Melan A+ immunostaining including a weak to moderate staining in melanocytic dendrites. Adrenal gland: An at least moderate Melan A+ immunostaining should be seen in adrenocortical cells.
Product Description/Background: Melan A antibody validated for immunohistochemistry on 76 different Normal Tissues
Negative Control: Kidney: Melan A immunostaining should be absent in all cells. Adrenal gland: Melan A+ immunostaining should be absent in all medullary cells.
-
实验流程
- Freshly cut sections should be used (less than 10 days between cutting and staining). Heat-induced antigen retrieval for 5 minutes in an autoclave at 121 °C in pH 7,8 Target Retrieval Solution buffer. Apply the antibody at a dilution of 1:75 at 37 °C for 60 minutes.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
储存条件
- 4 °C,-20 °C,-80 °C
-
储存方法
- Antibody with azide - store at 2 to 8 C. Antibody without azide - store at -20 to -80 C. Antibody is stable for 24 months. Non- hazardous. No MSD required.
-
有效期
- 24 months
-
-
- MLANA (Melan A (MLANA))
-
别名
- MLANA
-
背景
- Gene Alias: Antigen LB39-AA, Antigen SK29-AA, Melanoma antigen recognized by T-cells 1, MLAN-A, MLANA
-
UniProt
- Q16655
抗原
-